LGC BIOSEARCH Webinars
| Collaborating for effective genomic surveillance of SARS-CoV-2 variants |
Abstract
Get a behind-the-scenes look at how Dr. Richard Michelmore, Director of the Genome Center at UC Davis, set up a PCR-based testing workflow for SARS-CoV-2 in 6 weeks and is now leading an exemplary genomic surveillance programme for emerging variants of concern. This panel discussion reveals lessons learned on the essential feedback loop with LGC, Biosearch Technologies to ensure variant detection panels remain accurate.
Topics covered
- Lessons learned from setting up a high-throughput PCR-based SARS-CoV-2 testing centre.
- Clinical implications for monitoring emerging SARS-CoV-2 mutations and variants of concern.
- Cross-organisational collaboration in maintaining the accuracy of PCR-based detection panels for a robust genomic surveillance programme.
Speakers
Dr. Richard Michelmore
Director, Genome Center,
UC Davis
Dr. Tania Nolan
Head of Assay Design and Development,
LGC Biosearch Technologies
Dr. Lutz Froenicke
Manager, DNA Technologies Core – Genome Center
UC Davis
Dr. Lindy McClelland
Senior Scientist, Assay Design and Development Team
LGC, Biosearch Technologies